PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
08-Feb-2023 CureVac Announces Pricing of Upsized Public Offering of Common Shares CureVac
07-Feb-2023 iTeos to Present at SVB Securities Global Biopharma Conference iTeos Therapeutics
07-Feb-2023 AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43 AC Immune
07-Feb-2023 Pharmaceutical Serialisation – What’s Coming Down the Line? Domino Printing Sciences
07-Feb-2023 New Country Managing Director and Head of Human Pharma appointed for Boehringer Ingelheim UK & Ireland Boehringer Ingelheim UK & Ireland
07-Feb-2023 Oxford Science Enterprises strengthens Life Sciences investment team with appointment of Sanne de Jongh as Partner Oxford Science Enterprises
07-Feb-2023 Moberg Pharmas Year-end report 2022 Moberg Pharma
07-Feb-2023 Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer Evotec SE
07-Feb-2023 Enno Spillner appointed Chief Financial Officer (CFO) of Formycon AG Formycon AG
06-Feb-2023 CureVac Announces Proposed Public Offering of Common Shares CureVac
06-Feb-2023 SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing SYNLAB AG
06-Feb-2023 SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes SYNLAB AG
06-Feb-2023 iotaSciences Launches New isoPick™ Single-Cell Picker to Further Expand Handling Solutions for Efficient Cell Biology & Gene Therapy Applications B3C newswire
06-Feb-2023 DEFENCE MANUFACTURING ITS ARM VACCINE IN PREPARATION FOR PHASE I CLINICAL TRIAL AGAINST SOLID TUMORS Defence Therapeutics Inc.
06-Feb-2023 Aflibercept Biosimilar Candidate FYB203 shows comparable efficacy to the reference product Eylea®1 in Phase III Study Formycon AG
03-Feb-2023 IMFINZI (DURVALUMAB) IN COMBINATION WITH GEMCITABINE AND CISPLATIN APPROVED IN GREAT BRITAIN AS A FIRST-LINE TREATMENT FOR ADULT PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC BILIARY TRACT CANCER AstraZeneca
03-Feb-2023 Tezspire approved for self-administration in the US with a new pre-filled pen AstraZeneca
03-Feb-2023 CAS and Torx Software collaborate to streamline and accelerate small molecule discovery and design Torx Software
03-Feb-2023 AC Immune to Present at the SVB Securities Global Biopharma Conference AC Immune
03-Feb-2023 OptiBiotix to showcase its progressive microbiome research at Probiota 2023 OptiBiotix